TOPFUND WHERE YOUR MONEY GROWS
Home / Stocks / Dr Agarwals Health Care L
AGARWALEYE

Dr Agarwals Health Care L Share Price

Live price, chart and which mutual funds hold this stock

TopFund Score: 64/100 · Average See breakdown ↓
…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 25 Sep 2026

₹500.0

Change

-2.1 (-0.42%)

Open

₹503.0

Prev. Close

₹502.1

Day High

₹503.05

Day Low

₹492.85

Volume Analysis

Traded

242,336

Delivered

108,232

Delivery %

44.66%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Strong operating margin (28.0%)

Weaknesses (1)

  • •Low return on equity (5.99%)

Opportunities (1)

  • •Strong 3-year revenue growth (26.9%)

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹514.61 ₹508.83 ₹504.41 ₹498.63 ₹494.21 ₹488.43 ₹484.01
Fibonacci ₹508.83 ₹504.93 ₹502.53 ₹498.63 ₹494.73 ₹492.33 ₹488.43
Camarilla ₹502.81 ₹501.87 ₹500.94 ₹498.63 ₹499.07 ₹498.13 ₹497.2

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-0.05%

1 Week

+1.98%

1 Month

-1.54%

3 Months

+4.4%

6 Months

+19.19%

1 Year

+2.29%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹77.71

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

8.66%

Net margin 8.38% × asset turnover 0.53x × equity multiplier 1.95x

Company Overview

Sector

Healthcare

Market Cap

₹15,686 Cr

P/E (TTM)

106.0

ROE

5.99%

Book Value

₹63.9

Face Value

₹1.0

Source: Screener.in (Consolidated figures) — data as of 24 Sep 2026. Not investment advice.

TopFund Analysis

Dr Agarwals Health Care L lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 64/100. The strongest factor is Growth (100/100), while Valuation (1/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (28.0%); low return on equity (5.99%). FII holding has been falling.

TopFund Score — Fundamentals Quality

64/100 — Average

Data confidence: 77/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 27 Sep 2026 · How we calculate this →

Financial Strength

86

Growth

100

Valuation

1

Cash Flow

79

Corporate Governance

44

Momentum

56

Institutional Ownership

60

Business Quality

62

Risk & Volatility

89

Liquidity

54

From Screener.in

  • −Stock is trading at 7.74 times its book value
  • −Though the company is reporting repeated profits, it is not paying out dividend
  • −Company has a low return on equity of 5.62% over last 3 years.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 21 Sep 21 Sep
Shareholder Meeting / Postal Ballot-Outcome of AGM 21 Sep 21 Sep
Announcement under Regulation 30 (LODR)-Newspaper Publication 29 Aug

Newspaper Advertisement - Sixteenth Annual General Meeting of Dr. Agarwals Health Care Limited, Instructions for e-Voting and Other Related Information, is submitted.

Reg. 34 (1) Annual Report. 28 Aug 28 Aug
Sixteenth Annual General Meeting Of Dr Agarwals Health Care Limited To Be Held On September 21, 2026 28 Aug 28 Aug

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Sales + 333 349 403 417 431 460 487 499 530 564 614
Expenses + 244 241 300 310 316 329 360 363 386 403 444
Operating Profit 89 108 104 107 115 131 128 136 144 161 170
OPM % 27.0% 31.0% 26.0% 26.0% 27.0% 28.0% 26.0% 27.0% 27.0% 29.0% 28.0%
Other Income + 12 20 6 12 13 13 13 8 11 14 6
Interest 22 27 27 28 28 25 25 23 21 22 23
Depreciation 43 47 56 57 58 60 63 68 69 77 78
Profit before tax 36 54 27 33 41 59 54 54 65 77 75
Tax % 37.0% 24.0% 33.0% 36.0% 31.0% 27.0% 29.0% 32.0% 33.0% 35.0% 27.0%
Net Profit + 23 41 18 21 28 43 38 36 44 50 55
EPS in Rs — — — — 1 1 1 1 1 1 1
Raw PDF — — — — — — — — — — —

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 531 471 696 1,018 1,332 1,711 2,080 2,207
Expenses + 407 387 510 743 965 1,248 1,503 1,595
Operating Profit 124 85 186 275 367 463 577 612
OPM % 23.0% 18.0% 27.0% 27.0% 28.0% 27.0% 28.0% 28.0%
Other Income + 13 6 17 14 44 43 46 39
Interest 54 44 49 76 101 115 98 89
Depreciation 93 95 98 128 170 231 276 292
Profit before tax -11 -48 57 84 141 160 249 270
Tax % 82.0% 21.0% 24.0% -24.0% 32.0% 31.0% 32.0% —
Net Profit + -21 -59 43 103 95 110 168 185
EPS in Rs — — — — — 3 4 5
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% —

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Reserves 242 177 206 622 1,330 1,835 1,994
Borrowings + 162 185 633 857 966 961 1,066
Other Liabilities + 339 417 179 336 445 837 849
Total Liabilities 751 787 1,025 1,823 2,751 3,665 3,941
Fixed Assets + 551 575 701 1,293 1,746 2,523 2,870
CWIP 8 11 28 99 118 153 244
Investments 1 0 0 34 471 264 152
Other Assets + 192 201 295 397 416 724 675
Total Assets 751 787 1,025 1,823 2,751 3,665 3,941
Equity Capital 7 7 7 8 9 32 32

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 103 99 164 233 346 357 519
Cash from Investing Activity + -85 -46 -155 -509 -914 -750 -308
Cash from Financing Activity + -73 -37 35 303 553 382 -220
Net Cash Flow -56 17 44 27 -15 -11 -10
CFO/OP 97 126 97 98 103 85 99
Free Cash Flow -98 66 95 76 118 37 59

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 32.45% → 32.34%
  Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Public 1.74% 1.87% 1.52% 1.78% 1.87% 1.97%
Promoters 32.45% 32.43% 32.43% 32.39% 32.35% 32.34%
FII 60.62% 59.26% 58.13% 58.06% 57.94% 57.97%
DII 5.21% 6.44% 7.92% 7.78% 7.83% 7.72%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Dr Agarwals Health Care L (this stock) 15,686 106.0 7.75 5.99%
Vijaya Diagnostic Cen Ltd 15,590 83.2 16.28 18.3%
Syngene International Ltd 15,287 51.6 3.16 7.78%
Marksans Pharma Limited 15,269 29.6 5.05 15.2%
Concord Biotech Limited 16,142 58.1 7.99 12.5%
Molbio Diagnostics Ltd 15,118 60.6 — 15.6%
Natco Pharma Ltd. 15,033 13.1 1.63 17.1%

Which Mutual Funds Hold Dr Agarwals Health Care L?

Frequently Asked Questions about Dr Agarwals Health Care L

Community Sentiment

What are other investors saying about Dr Agarwals Health Care L?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.